At ReNew, our psychiatric nurse practitioners provide therapeutic support as part of a comprehensive treatment approach not as traditional standalone talk therapy, but woven into the ketamine-assisted psychotherapy (KAP) process
Conclusion The rise of GLP-1 microdosing may help patients achieve a more targeted approach to managing the unique metabolic shifts of perimenopause and menopause
It has multiple actions including: potentiation of glucose-mediated insulin secretion mechanisms identified: increased -cell proliferation, resulting in an increase -cell mass (Fusco et al, 2017) stimulation of insulin biosynthesis at the translational level, helping to maintain -cell insulin stores and secretory capacity (Baggio & Drucker, 2007) because the GLP-1 effect is glucose-dependent (there is more insulin release when glucose levels are elevated, but less effect when glucose levels are normal), GLP-1 agonists have a lower risk for producing hypoglycemia compared to sulfonylureas (that chronically stimulate insulin release, independent of glucose concentration) suppression of postprandial glucagon release Evidence indicates that stimulation of pancreatic cells by GLP-1 increases their glucose sensitivity, resulting in less glucagon release at any glucose level (Baggio & Drucker, 2007)
Sleep and stress management are often overlooked factors
What is in KLOW
Many people report that injecting into the abdomen causes more immediate or intense nausea compared to the thigh
